ロード中...

LDL Cholesterol, Statins And PCSK 9 Inhibitors

Reduction of low density lipoprotein cholesterol (LDLc) is of vital importance for the prevention of atherosclerotic cardiovascular disease (ASCVD). Statin is the most effective therapy today to lower LDLc by inhibiting HMG-CoA-reductase. However despite intensive statin therapy, there remains a res...

詳細記述

保存先:
書誌詳細
出版年:Indian Heart J
第一著者: Gupta, Sanjiv
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593843/
https://ncbi.nlm.nih.gov/pubmed/26432726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.05.020
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!